Use of donor lymphocyte infusions (DLI) for the treatment of relapse after allogeneic bone marrow transplantation (ABMT): Effective GVT in chronic myeloid leukemia (CML) with no clinical GVHD.

被引:0
|
作者
Hahn, TE [1 ]
Alam, AR [1 ]
Miller, A [1 ]
Meteer, J [1 ]
Dascomb, S [1 ]
Baer, MR [1 ]
Bambach, B [1 ]
Bernstein, S [1 ]
Bernstein, Z [1 ]
Chanan-Khan, A [1 ]
Czuczman, M [1 ]
Slack, J [1 ]
Wetzler, M [1 ]
Becker, J [1 ]
Stewart, C [1 ]
McCarthy, PL [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5239
引用
收藏
页码:366B / 366B
页数:1
相关论文
共 50 条
  • [41] DONOR BUFFY COAT TRANSFUSIONS (BC) FOR TREATMENT OF RELAPSED CHRONIC MYELOID-LEUKEMIA (CML) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    HERTENSTEIN, B
    BUNJES, D
    NOVOTNY, J
    WIESNETH, M
    HEINZE, B
    HEIMPEL, H
    ARNOLD, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1107 - 1107
  • [42] Effective treatment with imatinib mesylate and donor lymphocyte infusion following relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Li, JY
    Wu, HX
    Qian, SX
    Hong, M
    Xiao, B
    Zhang, R
    Ruan, CG
    BLOOD, 2005, 106 (11) : 441B - 441B
  • [43] MOLECULAR ANALYSIS OF RELAPSE IN CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GANESAN, TS
    MIN, GL
    GOLDMAN, JM
    YOUNG, BD
    BLOOD, 1987, 70 (03) : 873 - 876
  • [44] Second bone marrow transplant (2BMT) and donor leukocyte infusions (DLI) to treat relapse or graft failure after allogeneic bone marrow transplantation (BMT).
    VelaOjeda, J
    TrippVillanueva, F
    SanchezCortes, E
    AyalaSanchez, M
    GonzalezLlaven, J
    BLOOD, 1997, 90 (10) : 4479 - 4479
  • [45] A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
    Schattenberg, Anton V. M. B.
    Baynes, Christopher
    Van Dijk, Marcory C. R. F.
    Koster, Ad
    Van Cleef, Patricia H. J.
    Preijers, Frank W. M. B.
    Hermus, Adr.
    Raemaekers, John M. M.
    LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 1188 - 1190
  • [46] Donor leukocyte infusions (DLI) to treat relapses after allogeneic bone marrow transplantation in pediatric patients.
    Levine, JE
    Yanik, G
    Hutchinson, RJ
    Casper, J
    Beatty, PC
    Sproles, A
    Collins, R
    BLOOD, 1997, 90 (10) : 2439 - 2439
  • [47] Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions
    Cwynarski, K
    Goulding, R
    Pocock, C
    Dazzi, F
    Craddock, C
    Kaeda, J
    Olavarria, E
    Kanfer, E
    Apperley, J
    Lawler, M
    Goldman, JM
    BONE MARROW TRANSPLANTATION, 2001, 28 (06) : 581 - 586
  • [48] Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions
    K Cwynarski
    R Goulding
    C Pocock
    F Dazzi
    C Craddock
    J Kaeda
    E Olavarria
    E Kanfer
    J Apperley
    M Lawler
    JM Goldman
    Bone Marrow Transplantation, 2001, 28 : 581 - 586
  • [49] Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand
    Dazzi, F
    Szydlo, RM
    Goldman, JM
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (10) : 1477 - 1486
  • [50] Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation
    Gómez, M
    Urbano-Ispizua, A
    Cervantes, F
    Fernández-Avilés, F
    Rovira, M
    Carreras, E
    HAEMATOLOGICA, 2002, 87 (09) : 1003 - 1005